These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 4795642)

  • 1. Letter: Papanicolaou smears.
    Schapera R
    S Afr Med J; 1973 Sep; 47(38):1728. PubMed ID: 4795642
    [No Abstract]   [Full Text] [Related]  

  • 2. Cervical cytology in Natal: a progress report.
    Rockey T
    S Afr Med J; 1968 Aug; 42(31):807-11. PubMed ID: 5683045
    [No Abstract]   [Full Text] [Related]  

  • 3. Papanicolaou smears in general practice.
    Rösemann GW
    S Afr Med J; 1967 Jun; 41(23):579-81. PubMed ID: 6028819
    [No Abstract]   [Full Text] [Related]  

  • 4. Pap smears in the Third World.
    Lahri S
    S Afr Med J; 2007 Jul; 97(7):474-5. PubMed ID: 17805441
    [No Abstract]   [Full Text] [Related]  

  • 5. Exfoliative cytology in the early detection of cervical carcinoma in General Practice.
    Lawrence RA
    J R Coll Gen Pract; 1968 Nov; 16(5):379-91. PubMed ID: 5722471
    [No Abstract]   [Full Text] [Related]  

  • 6. Automatic screening of Papanicolaou stained cervical smears with the T. A. S.
    Meyer F; van Driel A
    Microsc Acta Suppl; 1980; Suppl 4():82-95. PubMed ID: 6157078
    [No Abstract]   [Full Text] [Related]  

  • 7. Do cervical smears save lives?
    Br Med J; 1969 Jun; 2(5657):585-6. PubMed ID: 5798464
    [No Abstract]   [Full Text] [Related]  

  • 8. [The significance of cytodiagnosis as a screening method in the domain of early diagnosis of cervix cancer and its early stages for the general practioner].
    Bötzelen HP; Meyer K
    Z Allgemeinmed; 1964 Dec; 40(36):1549-51. PubMed ID: 5889485
    [No Abstract]   [Full Text] [Related]  

  • 9. Cervical cancer after negative Papanicolaou smears.
    Hasselbrack R
    Obstet Gynecol; 1985 May; 65(5):771. PubMed ID: 3982757
    [No Abstract]   [Full Text] [Related]  

  • 10. Microinvasive cervical cancer after five negative Papanicolaou smears.
    Erozan Y; Rosenshein NB; Parmley TH; Woodruff JD
    Obstet Gynecol; 1983 Sep; 62(3 Suppl):82s. PubMed ID: 6877718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cytology revisited.
    Fulghum JE; Reagan JC
    JFMA; 1973 May; 60(5):Suppl:31-5. PubMed ID: 4735203
    [No Abstract]   [Full Text] [Related]  

  • 12. [Efficacy of cytodiagnosis of cervix cancer during prophylactic examinations].
    Gladysheva VA; Chernova VD; Ivanova AV
    Lab Delo; 1982; (9):519-21. PubMed ID: 6183511
    [No Abstract]   [Full Text] [Related]  

  • 13. Local mass cytologic screening for cancer of the cervix.
    Wallace D; Slankard JE
    Mo Med; 1972 Jun; 69(6):438-9 passim. PubMed ID: 5028742
    [No Abstract]   [Full Text] [Related]  

  • 14. [Gynecologic cytodiagnosis in general practice].
    Bajardi F
    Osterr Z Erforsch Bekampf Krebskr; 1970; 25(4):222-36. PubMed ID: 5536606
    [No Abstract]   [Full Text] [Related]  

  • 15. [A comparison between mass screening for uterine neck cancer in the Districts of Frederiksberg and Maribo].
    Koch F; Klinken L; Albrechtsen R
    Nord Med; 1971 Dec; 86(50):1534. PubMed ID: 5135061
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening for cervical cancer.
    Wachtel E
    Practitioner; 1973 Aug; 211(262):137-42. PubMed ID: 4580608
    [No Abstract]   [Full Text] [Related]  

  • 17. The value of mass cytological screening programme in the early detection of cervical cancer.
    Devi NN; Vijayalakshmi A; Nair MB; Devi KR
    J Indian Med Assoc; 1974 Aug; 63(3):92-5. PubMed ID: 4443577
    [No Abstract]   [Full Text] [Related]  

  • 18. [Concrete results of a first mass investigation of vaginal cytology].
    De Jaco M; Regolisti A; Veggetti GP
    Pathologica; 1966; 58(863):249-59. PubMed ID: 5990358
    [No Abstract]   [Full Text] [Related]  

  • 19. High prevalence of abnormal Pap smears among young women co-infected with HIV in rural South Africa - implications for cervical cancer screening policies in high HIV prevalence populations.
    Gaym A; Mashego M; Kharsany AB; Walldorf J; Frohlich J; Karim QA
    S Afr Med J; 2007 Feb; 97(2):120-3. PubMed ID: 17404673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focusing on issues impacting on biomedical scientists, cytotechnologists and cytology screeners.
    Wilson A
    Cytopathology; 2015 Feb; 26(1):7-9. PubMed ID: 25683359
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.